197 related articles for article (PubMed ID: 22363625)
1. The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.
Serber DW; Rogala A; Makarem M; Rosson GB; Simin K; Godfrey V; Van Dyke T; Eaves CJ; Bultman SJ
PLoS One; 2012; 7(2):e31346. PubMed ID: 22363625
[TBL] [Abstract][Full Text] [Related]
2. Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.
Willis MS; Homeister JW; Rosson GB; Annayev Y; Holley D; Holly SP; Madden VJ; Godfrey V; Parise LV; Bultman SJ
Circ Res; 2012 Aug; 111(5):e111-22. PubMed ID: 22740088
[TBL] [Abstract][Full Text] [Related]
3. Characterization of mammary tumors from Brg1 heterozygous mice.
Bultman SJ; Herschkowitz JI; Godfrey V; Gebuhr TC; Yaniv M; Perou CM; Magnuson T
Oncogene; 2008 Jan; 27(4):460-8. PubMed ID: 17637742
[TBL] [Abstract][Full Text] [Related]
4. Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.
Smith-Roe SL; Bultman SJ
Mamm Genome; 2013 Feb; 24(1-2):21-9. PubMed ID: 23076393
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.
Cohet N; Stewart KM; Mudhasani R; Asirvatham AJ; Mallappa C; Imbalzano KM; Weaver VM; Imbalzano AN; Nickerson JA
J Cell Physiol; 2010 Jun; 223(3):667-78. PubMed ID: 20333683
[TBL] [Abstract][Full Text] [Related]
6. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
[TBL] [Abstract][Full Text] [Related]
7. The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.
Trotter KW; Fan HY; Ivey ML; Kingston RE; Archer TK
Mol Cell Biol; 2008 Feb; 28(4):1413-26. PubMed ID: 18086889
[TBL] [Abstract][Full Text] [Related]
8. SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice.
Wiley MM; Muthukumar V; Griffin TM; Griffin CT
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25904594
[TBL] [Abstract][Full Text] [Related]
9. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development.
Griffin CT; Brennan J; Magnuson T
Development; 2008 Feb; 135(3):493-500. PubMed ID: 18094026
[TBL] [Abstract][Full Text] [Related]
10. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
11. Brg1 Controls the Expression of Pax7 to Promote Viability and Proliferation of Mouse Primary Myoblasts.
Padilla-Benavides T; Nasipak BT; Imbalzano AN
J Cell Physiol; 2015 Dec; 230(12):2990-7. PubMed ID: 26036967
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
13. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
14. Genetic mechanisms in Apc-mediated mammary tumorigenesis.
Kuraguchi M; Ohene-Baah NY; Sonkin D; Bronson RT; Kucherlapati R
PLoS Genet; 2009 Feb; 5(2):e1000367. PubMed ID: 19197353
[TBL] [Abstract][Full Text] [Related]
15. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a Brg1 hypomorphic allele demonstrates that genetic and biochemical activity are tightly correlated.
Chandler RL; Zhang Y; Magnuson T; Bultman SJ
Epigenetics; 2014 Feb; 9(2):249-56. PubMed ID: 24172864
[TBL] [Abstract][Full Text] [Related]
17. SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity.
Reske JJ; Wilson MR; Holladay J; Wegener M; Adams M; Chandler RL
Hum Mol Genet; 2020 Dec; 29(20):3412-3430. PubMed ID: 33075803
[TBL] [Abstract][Full Text] [Related]
18. Cdx2 Regulates Gene Expression through Recruitment of Brg1-associated Switch-Sucrose Non-fermentable (SWI-SNF) Chromatin Remodeling Activity.
Nguyen TT; Savory JGA; Brooke-Bisschop T; Ringuette R; Foley T; Hess BL; Mulatz KJ; Trinkle-Mulcahy L; Lohnes D
J Biol Chem; 2017 Feb; 292(8):3389-3399. PubMed ID: 28082674
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
Kimura A; Arakawa N; Hirano H
J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
[TBL] [Abstract][Full Text] [Related]
20. Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Rago F; Rodrigues LU; Bonney M; Sprouffske K; Kurth E; Elliott G; Ambrose J; Aspesi P; Oborski J; Chen JT; McDonald ER; Mapa FA; Ruddy DA; Kauffmann A; Abrams T; Bhang HC; Jagani Z
Mol Cancer Res; 2022 Mar; 20(3):361-372. PubMed ID: 34799403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
